COSELA
Active substance: trilaciclib
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TRILACICLIB DIHYDROCHLORIDE 300 mg/20mL
United StatesActive
Marketing holder: Pharmacosmos Therapeutics Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- TRILACICLIB DIHYDROCHLORIDE · 300 mg/20mL
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2ed9-719c-8370-fc713b44bcd5,01a12090-f257-7524-9f05-43b34a28bc0b;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 73594-0101
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 73594-0101 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 73594-0101 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 73594-0101 · Verified 2026-10-09 · open in source